pyrazines has been researched along with Connective Tissue Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkson, L; Chartrand, S; Langleben, D | 1 |
1 other study(ies) available for pyrazines and Connective Tissue Diseases
| Article | Year |
|---|---|
Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
Topics: Acetamides; Antihypertensive Agents; Connective Tissue Diseases; Epoprostenol; Humans; Ischemia; Pyrazines; Raynaud Disease | 2021 |